Mcmorgan & CO LLC Thermo Fisher Scientific Inc. Transaction History

Mcmorgan & CO LLC

$632 Million
Q3 2024

A detailed history of Mcmorgan & CO LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Mcmorgan & CO LLC holds 893 shares of TMO stock, worth $460,948. This represents 0.09% of its overall portfolio holdings.

Number of Shares

893

Previous 898 0.56%

Holding current value

$460,948

Previous $496,000 11.29%

% of portfolio

0.09%

Previous 0.08%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$531.86 - $624.21 $2,659 - $3,121	-5 Reduced 0.56%	893 $552,000
Q2 2024 Aug 14, 2024	SELL	$541.52 - $599.02 $97,473 - $107,823	-180 Reduced 16.7%	898 $496,000
Q1 2024 May 15, 2024	SELL	$528.82 - $599.43 $10,576 - $11,988	-20 Reduced 1.82%	1,078 $626,000
Q3 2023 Nov 13, 2023	SELL	$498.29 - $574.41 $9,965 - $11,488	-20 Reduced 1.79%	1,098 $555,000
Q2 2023 Aug 14, 2023	SELL	$508.46 - $591.13 $5,084 - $5,911	-10 Reduced 0.89%	1,118 $583,000
Q1 2023 May 15, 2023	SELL	$535.0 - $604.82 $18,725 - $21,168	-35 Reduced 3.01%	1,128 $650,000
Q4 2022 Feb 14, 2023	BUY	$484.71 - $571.37 $2,423 - $2,856	5 Added 0.43%	1,163 $640,000
Q2 2022 Aug 15, 2022	SELL	$500.9 - $612.21 $15,027 - $18,366	-30 Reduced 2.53%	1,158 $629,000
Q1 2022 May 17, 2022	SELL	$524.0 - $644.92 $31,440 - $38,695	-60 Reduced 4.81%	1,188 $701,000
Q4 2021 Feb 14, 2022	BUY	$569.0 - $667.24 $156,475 - $183,491	275 Added 28.26%	1,248 $833,000
Q3 2021 Nov 15, 2021	BUY	$509.53 - $609.78 $495,772 - $593,315	973 New	973 $555,000

Others Institutions Holding TMO

# of Institutions

2,836

Shares Held

334M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $202B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcmorgan & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcmorgan & CO LLC with notifications on news.

Account